iN Therapeutics Co., Ltd. clinical trials

A subsidiary of Daewoong Pharmaceutical Co. LTD.

The registry lists 2 studies whose lead sponsor is iN Therapeutics Co., Ltd.. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 24, 2024.

Status

Recruiting: 1
Completed: 1

Phase

Phase 1: 2

Where

Australia: 2

Registry sponsor names on this page

iN Therapeutics Co., Ltd.2 studies

Something wrong with this grouping? Tell us on the Daewoong Pharmaceutical Co. LTD. page.

Studies

Recruiting first, then most recently updated. Showing 2 of 2. All Daewoong Pharmaceutical Co. LTD. studies →

A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.RecruitingNCT06218784Phase 1
Sponsor listed in the registry: iN Therapeutics Co., Ltd.
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy VolunteersCompletedNCT05496205Phase 1
Sponsor listed in the registry: iN Therapeutics Co., Ltd.